GTHP GUIDED THERAPEUTICS INC OTC · United States

GUIDED THERAPEUTICS INC (GTHP) news

GUIDED THERAPEUTICS INC is a public biotech or pharmaceutical company listed on OTC under the ticker GTHP, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest GUIDED THERAPEUTICS INC news

We have not published a story on GUIDED THERAPEUTICS INC yet. When there is news, it will appear here.

GUIDED THERAPEUTICS INC annual financials

Line	FY2025	FY2024
Revenue	$767,000	$7,000
Research and development	$469,000	$526,000
Net income (loss)	-$3.2 million	-$2.4 million
Cash from operations	-$1.1 million	-$1.1 million
Cash and equivalents	$63,000	$388,000

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $12,000.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about GUIDED THERAPEUTICS INC

What is the ticker symbol of GUIDED THERAPEUTICS INC?

GUIDED THERAPEUTICS INC trades under the ticker GTHP on OTC.

Where is GUIDED THERAPEUTICS INC listed?

GUIDED THERAPEUTICS INC is listed on OTC.

Which country or territory is GUIDED THERAPEUTICS INC listed under?

Our directory records GUIDED THERAPEUTICS INC under United States.

Does aibio.space cover GUIDED THERAPEUTICS INC?

aibio.space lists GUIDED THERAPEUTICS INC among 2,820 public biotech companies and publishes its news here as stories appear.

What was GUIDED THERAPEUTICS INC's revenue last year?

$767,000 for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is GUIDED THERAPEUTICS INC profitable?

GUIDED THERAPEUTICS INC reported a net loss of $3.2 million for the fiscal year ended Dec 31, 2025, and used $1.1 million of cash in operations, per its annual report to the SEC.

How much does GUIDED THERAPEUTICS INC spend on research and development?

$469,000 in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does GUIDED THERAPEUTICS INC have?

$12,000 in cash at Jun 30, 2026, per its 10-Q.

Investor discussion: GUIDED THERAPEUTICS INC

Members talk about GUIDED THERAPEUTICS INC (GTHP). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:GTHP on TradingView.

Listing details

Company: GUIDED THERAPEUTICS INC
Ticker: GTHP
Listing: OTC
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction